Johnson & Johnson (NYSE:JNJ) — Stock Price
Johnson & Johnson (NYSE:JNJ) is currently trading at $261.81 USD, up 0.99% today. Over the past 52 weeks, shares have ranged between $172.78 and $267.24. This page tracks Johnson & Johnson's live share price on the NYSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Johnson & Johnson market cap and net worth.
Johnson & Johnson (JNJ) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Johnson & Johnson's daily closing share price and trading volume on the NYSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Johnson & Johnson Income Statement — Revenue, Profit & Earnings by Year
Johnson & Johnson's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $94.19 Billion | $88.82 Billion | $85.16 Billion | $79.99 Billion | $78.74 Billion |
| Cost of Revenue | $25.64 Billion | $27.47 Billion | $26.74 Billion | $24.60 Billion | $23.40 Billion |
| Gross Profit | $68.56 Billion | $61.35 Billion | $58.41 Billion | $55.39 Billion | $55.34 Billion |
| Research & Development | $14.66 Billion | $17.23 Billion | $15.05 Billion | $14.13 Billion | $14.28 Billion |
| SG&A | $23.68 Billion | $21.97 Billion | $21.01 Billion | $20.25 Billion | $20.12 Billion |
| Total Operating Expenses | $42.96 Billion | $66.67 Billion | $36.56 Billion | $34.38 Billion | $34.40 Billion |
| Operating Income | $25.60 Billion | $22.15 Billion | $21.85 Billion | $21.01 Billion | $20.94 Billion |
| EBITDA | $32.58 Billion | $24.78 Billion | $29.34 Billion | $26.61 Billion | $26.75 Billion |
| EBIT | — | $17.44 Billion | $21.85 Billion | $19.64 Billion | $19.36 Billion |
| Interest Expense | $85.00 Million | $755.00 Million | $1.25 Billion | $276.00 Million | $183.00 Million |
| Income Before Tax | $32.58 Billion | $16.69 Billion | $15.06 Billion | $19.36 Billion | $19.18 Billion |
| Income Tax Expense | $5.78 Billion | $2.62 Billion | $1.74 Billion | $2.99 Billion | $1.38 Billion |
| Net Income | $26.80 Billion | $14.07 Billion | $35.15 Billion | $17.94 Billion | $20.88 Billion |
Johnson & Johnson Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Johnson & Johnson's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | $180.10 Billion | $167.56 Billion | $187.38 Billion | $182.02 Billion | $174.89 Billion |
| Total Current Assets | $55.89 Billion | $53.49 Billion | $55.29 Billion | $60.98 Billion | $51.24 Billion |
| Cash & Equivalents | $6.12 Billion | $4.81 Billion | $5.37 Billion | $1.90 Billion | $2.10 Billion |
| Short-term Investments | $417.00 Million | $1.07 Billion | $9.39 Billion | $17.12 Billion | $11.20 Billion |
| Net Receivables | $18.93 Billion | $14.87 Billion | $16.91 Billion | $18.98 Billion | $13.58 Billion |
| Inventory | $12.44 Billion | $11.18 Billion | $10.27 Billion | $10.39 Billion | $9.34 Billion |
| Property, Plant & Equipment | $21.62 Billion | $20.90 Billion | $19.80 Billion | $18.96 Billion | $18.77 Billion |
| Goodwill | $44.20 Billion | $36.56 Billion | $36.05 Billion | $35.25 Billion | $36.39 Billion |
| Total Liabilities | $108.61 Billion | $98.78 Billion | $110.57 Billion | $108.00 Billion | $111.62 Billion |
| Total Current Liabilities | $50.32 Billion | $46.28 Billion | $55.80 Billion | $45.23 Billion | $42.49 Billion |
| Long-term Debt | $30.65 Billion | $25.88 Billion | $26.89 Billion | $29.98 Billion | $32.63 Billion |
| Net Debt | $12.53 Billion | $7.47 Billion | $26.75 Billion | $19.26 Billion | $21.28 Billion |
| Total Stockholder Equity | $71.49 Billion | $68.77 Billion | $76.80 Billion | $74.02 Billion | $63.28 Billion |
| Retained Earnings | $155.79 Billion | $153.84 Billion | $128.34 Billion | $123.06 Billion | $113.89 Billion |
Johnson & Johnson Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Johnson & Johnson generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | $24.27 Billion | $22.79 Billion | $21.19 Billion | $23.41 Billion | $23.54 Billion |
| Capital Expenditures | $4.42 Billion | $4.54 Billion | $4.01 Billion | $3.65 Billion | $3.35 Billion |
| Free Cash Flow | $19.84 Billion | $18.25 Billion | $17.18 Billion | $19.76 Billion | $20.19 Billion |
| Investing Cash Flow | $-18.60 Billion | $878.00 Million | $-12.37 Billion | $-8.68 Billion | $-20.82 Billion |
| Financing Cash Flow | $-3.13 Billion | $-15.82 Billion | $-8.87 Billion | $-14.05 Billion | $-6.12 Billion |
| Dividends Paid | $11.82 Billion | $11.77 Billion | $11.68 Billion | $11.03 Billion | $10.48 Billion |
| Stock-Based Compensation | $1.18 Billion | $1.16 Billion | $1.14 Billion | $1.14 Billion | $1.00 Billion |
| Depreciation | $7.34 Billion | $7.49 Billion | $6.97 Billion | $7.39 Billion | $7.23 Billion |
| Change in Cash | $2.25 Billion | $7.73 Billion | $-360.00 Million | $502.00 Million | $-3.32 Billion |
Johnson & Johnson Earnings History — EPS Actual vs. Analyst Estimates
Track Johnson & Johnson's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 14, 2026 | — | 2.69 | — |
| Jan 21, 2026 | 2.46 | 2.46 | +0.00% |
| Oct 14, 2025 | 2.80 | 2.76 | +1.45% |
| Jul 16, 2025 | 2.77 | 2.68 | +3.36% |
| Apr 15, 2025 | 4.54 | 2.26 | +100.89% |
| Jan 22, 2025 | 2.04 | 2.01 | +1.49% |
| Oct 15, 2024 | 2.42 | 2.21 | +9.50% |
| Jul 17, 2024 | 2.82 | 2.70 | +4.44% |